Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Ciplas subsidiary to acquire US-based Avenue Therapeutics for Rs 156 Crore

      Cipla's subsidiary to acquire US-based Avenue Therapeutics for Rs 156 Crore

      Medical Dialogues Bureau15 Nov 2018 9:55 AM IST
      New Delhi: Drug major Cipla has recently announced its subsidiary InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire...
      Aurobindo Pharma shares fall 3% after Q2 earnings

      Aurobindo Pharma shares fall 3% after Q2 earnings

      Medical Dialogues Bureau15 Nov 2018 9:45 AM IST
      New Delhi: Shares of Aurobindo Pharma has recently fallen almost 3 per cent after the company reported 21.70 per cent dip in consolidated net profit...
      IHH Healthcare completes Fortis Acquisition, Appoints 4 Directors on Board

      IHH Healthcare completes Fortis Acquisition, Appoints 4 Directors on Board

      Medical Dialogues Bureau14 Nov 2018 4:01 PM IST
      The board has also approved the appointment of four IHH-NTK's nominees Tan See Leng, Low Soon Teck, Chan Boon Kheng and Bhagat Chintamani Aniruddha as...
      Lupin launches Generic Pneumonia Drug Atovaquone Oral Suspension USP in US

      Lupin launches Generic Pneumonia Drug Atovaquone Oral Suspension USP in US

      Medical Dialogues Bureau14 Nov 2018 3:00 PM IST
      New Delhi: Drug giant Lupin has recently launched the generic Atovaquone oral suspension USP, which is used for the prevention and treatment of...
      Aurobindo to acquire under development product, related assets from Advent for Rs 90 crore

      Aurobindo to acquire under development product, related assets from Advent for Rs 90 crore

      Medical Dialogues Bureau14 Nov 2018 2:55 PM IST
      New Delhi: Drug firm Aurobindo Pharma has recently stated that its arm in the USA has signed a pact to acquire an under-development product and...
      Sun Pharma Q2 consolidated net loss at Rs 219 crore

      Sun Pharma Q2 consolidated net loss at Rs 219 crore

      Medical Dialogues Bureau14 Nov 2018 12:00 PM IST
      New Delhi: Drug giant Sun Pharmaceutical Industries (Sun Pharma) has reported a consolidated net loss of Rs 218.82 crore for the July-September...
      Roches Tecentriq gets instant FDA review in tough-to-treat breast cancer

      Roche's Tecentriq gets instant FDA review in tough-to-treat breast cancer

      Medical Dialogues Bureau14 Nov 2018 10:00 AM IST
      ZURICH: As the Swiss drugmaker seeks to be the first company to have its immunotherapy win approval in this indication, Roche's Tecentriq medicine...
      Glenmark teams up with South Korean firm SCD for ophthalmic products

      Glenmark teams up with South Korean firm SCD for ophthalmic products

      Medical Dialogues Bureau14 Nov 2018 9:36 AM IST
      New Delhi: To develop, manufacture and market a portfolio of ophthalmic products in the US and Canada, drug major Glenmark Pharmaceuticals has entered...
      Theravance, Mylan win USFDA approval for COPD Drug Yupelri

      Theravance, Mylan win USFDA approval for COPD Drug Yupelri

      Medical Dialogues Bureau14 Nov 2018 9:00 AM IST
      New Delhi: Mylan has recently announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Yupelri...
      Lupin gets EIR from USFDA for its Nagpur facility

      Lupin gets EIR from USFDA for its Nagpur facility

      Medical Dialogues Bureau13 Nov 2018 3:55 PM IST
      New Delhi: Drug firm Lupin Monday said it has received an establishment inspection report(EIR) from the US health regulator post the inspection of its...
      Nestle raises stake in food allergy drug developer Aimmune

      Nestle raises stake in food allergy drug developer Aimmune

      Medical Dialogues Bureau13 Nov 2018 3:53 PM IST
      The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to...
      Lupin gets USFDA nod for Asthma drug

      Lupin gets USFDA nod for Asthma drug

      Medical Dialogues Bureau13 Nov 2018 3:53 PM IST
      New Delhi: Drug major Lupin Tuesday said it has received approval from the US health regulator to market Budesonide Inhalation Suspension single-dose...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok